4//SEC Filing
Kennedy Lawrence T. Jr 4
Accession 0001140361-23-026717
CIK 0001439725other
Filed
May 24, 8:00 PM ET
Accepted
May 25, 6:21 PM ET
Size
6.4 KB
Accession
0001140361-23-026717
Insider Transaction Report
Form 4
BIODESIX INCBDSX
Kennedy Lawrence T. Jr
Director10% Owner
Transactions
- Award
Restricted Stock Units
2023-05-23+28,873→ 28,873 total→ Common Stock (28,873 underlying)
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.
- [F3]Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer.
- [F4]The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.
Documents
Issuer
BIODESIX INC
CIK 0001439725
Entity typeother
Related Parties
1- filerCIK 0001830773
Filing Metadata
- Form type
- 4
- Filed
- May 24, 8:00 PM ET
- Accepted
- May 25, 6:21 PM ET
- Size
- 6.4 KB